May 12, 2020 / 2:08 PM / 15 days ago

BRIEF-Abbott Receives FDA Emergency Use Authorization For Covid-19 Molecular Test On New Alinity M System

May 12 (Reuters) - Abbott Laboratories:

* ABBOTT RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR COVID-19 MOLECULAR TEST ON NEW ALINITY™ M SYSTEM

* ABBOTT LABORATORIES - LAUNCHING ALINITY M TO U.S. CUSTOMERS AND WILL BE MAKING SARS-COV-2 TEST AVAILABLE FOR USE UNDER AN EMERGENCY USE AUTHORIZATION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below